The Central Virginia Center on Drug Abuse Research
The Central Virginia Center on Drug Abuse Research
批准号:
10604263
负责人:
William L. Dewey
金额:
$138.02万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
未结题
起止时间:
2013-12-01 至 2025-03-31
关键词:
AnimalsAreaAtmosphereBasic ScienceBehaviorBibliographyBiomedical ResearchBody FluidsBrainBreedingCardiovascular systemChemicalsClinical ResearchCollaborationsCore FacilityCore GrantCountryCreativenessDiseaseDrug AddictionDrug abuseEndocannabinoidsEnvironmentEquipmentFacultyFinancial HardshipForensic MedicineFosteringFundingFunding OpportunitiesGastrointestinal tract structureGene ExpressionGenotypeGoalsGrantHumanInfrastructureInstitutionIon ChannelJournalsKnowledgeLaboratoriesLeadershipLettersLipidsMeasurementMeasuresMethodologyModernizationMusMutant Strains MiceNational Heart, Lung, and Blood InstituteNational Institute of Drug AbuseNational Institute of General Medical SciencesNational Institute of Neurological Disorders and StrokeNeuropharmacologyOpioidPaperPerformancePharmaceutical PreparationsPharmacology and ToxicologyPharmacy SchoolsPharmacy facilityPilot ProjectsProductivityPublicationsPublishingRecording of previous eventsRecordsResearchResearch PersonnelResourcesRunningSamplingScientistSignal TransductionSocietiesSubstance AddictionSubstance abuse problemTechnologyTissuesToxicologyTrainingTransgenic OrganismsUnited StatesUnited States National Institutes of HealthUniversitiesUpdateViral VectorVirginiaWorkbasebiological systemscravingdrug of abuseexperiencegastrointestinalgastrointestinal functiongastrointestinal systemimaging facilitiesimprovedinnovationinstrumentinterestliquid chromatography mass spectrometrymedical schoolsneurobehavioralnovelopioid epidemicpreventprogramsreceptorrecruitsuccesstool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary – Overall
One of the overall goals of this center is to provide an environment in which investigators can conduct new,
significant and innovative basic and clinical research utilizing bioanalytical technology, genetically altered mice,
neurobehavioral measures and gastrointestinal studies to advance our knowledge of the effects of abused drugs
on biological systems. Coordination through the Administrative Core will provide the necessary scientific,
financial, and administrative infrastructure to support such an environment. Further, this center will provide these
areas of expertise to enhance the research of the 21 projects in VCU's Department of Pharmacology and
Toxicology currently funded by NIDA and 13 funded through other NIH institutes (NIAAA: 2; NINDS: 2; NIGMS:
1; NCI: 1; NIDDKD: 4; NHLBI: 2) or other federal agencies (NSF: 1). These cores will provide current and
innovative expertise that is improved over the methodologies used in previously funded research. This will
enhance previously funded research and foster new collaborative research in ways that could not have been
contemplated just a few years ago. A Bioanalytical Core, Mutant Mouse/Viral Vector Core,
Neuropharmacology Core, and a Gastrointestinal Function Core will provide the opportunity for funded
researchers to broaden the scope of their work to transform knowledge in various creative ways. The ability to
continue to provide genetically altered mice with appropriate genotyping, etc., and expertise in viral vector
technology are major assets of this Center. Being able to have a collaborator elucidate receptor functional
changes as part of the neuropharmacology core, identify a substance found to alter behavior or craving in the
bioanalytical core, or identify deleterious effects in the gastrointestinal tract provides the atmosphere for new
and creative mechanistic research. This type of collaboration among scientists at different institutions is rare
and requires many months or perhaps years to establish, if at all. In this center this type of collaboration will be
the norm. We are committed to providing considerable institutional support, such as the use of a modern imaging
center and a forensic toxicology laboratory established by the university. We have commitments from the Dean
of the School of Medicine, the Dean of the School of Pharmacy, and the Vice President for Research and
Innovation to provide matching funds for our Pilot Projects program. The cores will also be available for
use by NIDA-funded investigators at the University of Virginia and Eastern Virginia Medical School. Scholars at
the relatively new Pharmacy School at Hampton University have begun collaborations with our researchers, as they
continue to develop and expand their research programs. We will also continue to share all aspects of this
center with scientists throughout the country. We have included numerous letters of support from collaborating
investigators at other institutions within Virginia and across the country, showcasing the strength of our Center
and its importance to drug abuse research being conducted throughout the United States.
期刊论文(44)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Examination of the behavioral effects of ketamine in Sprague-Dawley and Wistar Kyoto rats.
检查氯胺酮对 Sprague-Dawley 和 Wistar京都大鼠的行为影响。
DOI:
--
发表时间:
2022
期刊:
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
影响因子:
--
作者:
[Zhang,Fan, Baasansukh,Tegshjargal, Shelton,KeithL, Porter,JosephH, Nicholson,KatherineL]
通讯作者:
Nicholson,KatherineL
High-performance liquid chromatography with tandem mass spectrometry for the determination of nine hallucinogenic 25-NBOMe designer drugs in urine specimens.
采用高效液相色谱串联质谱法测定尿液样本中的 9 种致幻性 25-NBOMe 设计药物。
DOI:
10.1093/jat/bku005
发表时间:
2014
期刊:
Journal of analytical toxicology
影响因子:
2.5
作者:
[Poklis,JustinL, Clay,DeborahJ, Poklis,Alphonse]
通讯作者:
Poklis,Alphonse
Stability of Tetrahydrocannabinol and Cannabidiol in Prepared Quality Control Medible Brownies.
四氢大麻酚和大麻二酚在制备的质量控制食用布朗尼中的稳定性。
DOI:
10.1093/jat/bkw114
发表时间:
2017
期刊:
Journal of analytical toxicology
影响因子:
2.5
作者:
[Wolf,CarlE, Poklis,JustinL, Poklis,Alphonse]
通讯作者:
Poklis,Alphonse
DOI:
10.1037/pha0000391
发表时间:
2021-08
期刊:
Experimental and clinical psychopharmacology
影响因子:
2.3
作者:
[Peters EN, Herrmann ES, Smith C, Wilhelm JA, Koszowski B, Halquist M, Kosmider L, Poklis J, Roth S, Bart S, Pickworth WB]
通讯作者:
Pickworth WB
Identification of Drugs in Parenteral Pharmaceutical Preparations from a Quality Assurance and a Diversion Program by Direct Analysis in Real-Time AccuTOFTM-Mass Spectrometry (DART-MS).
通过实时 AccuTOFTM 质谱 (DART-MS) 直接分析,通过质量保证和转移程序鉴定肠外药物制剂中的药物。
DOI:
10.1093/jat/bkw065
发表时间:
2016
期刊:
Journal of analytical toxicology
影响因子:
2.5
作者:
[Poklis,JustinL, Mohs,AmandaJ, Wolf,CarlE, Poklis,Alphonse, Peace,MichelleR]
通讯作者:
Peace,MichelleR
共 21 条
Training in the pharmacology of abused drugs
-
批准号:9386216
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:William L. Dewey
-
依托单位:
The Central Virginia Center on Drug Abuse Research
-
批准号:9189703
-
项目类别:
-
资助金额:$59.74万
-
财政年份:2013
-
负责人:William L. Dewey
-
依托单位:
The Central Virginia Center on Drug Abuse Research
-
批准号:10374821
-
项目类别:
-
资助金额:$138.02万
-
财政年份:2013
-
负责人:William L. Dewey
-
依托单位:
The Central Virginia Center on Drug Abuse Research
-
批准号:8552155
-
项目类别:
-
资助金额:$65.18万
-
财政年份:2013
-
负责人:William L. Dewey
-
依托单位:
Administrative Core
-
批准号:10374822
-
项目类别:
-
资助金额:$18.35万
-
财政年份:2013
-
负责人:William L. Dewey
-
依托单位:
Administrative Core
-
批准号:10604264
-
项目类别:
-
资助金额:$18.35万
-
财政年份:2013
-
负责人:William L. Dewey
-
依托单位:
The Role of Protein Kinase C in Opioid Tolerance
-
批准号:7278267
-
项目类别:
-
资助金额:$24.77万
-
财政年份:2006
-
负责人:William L. Dewey
-
依托单位:
The Role of Protein Kinase C in Opioid Tolerance
-
批准号:7465564
-
项目类别:
-
资助金额:$24.75万
-
财政年份:2006
-
负责人:William L. Dewey
-
依托单位:
The Role of Protein Kinase C in Opioid Tolerance
-
批准号:7148489
-
项目类别:
-
资助金额:$25.6万
-
财政年份:2006
-
负责人:William L. Dewey
-
依托单位:
The Role of Protein Kinase C in Opioid Tolerance
-
批准号:7652489
-
项目类别:
-
资助金额:$24.64万
-
财政年份:2006
-
负责人:William L. Dewey
-
依托单位:
The Role of Protein Kinase C in Opioid Tolerance
-
批准号:7874580
-
项目类别:
-
资助金额:$29.16万
-
财政年份:2006
-
负责人:William L. Dewey
-
依托单位:
Effects of Opiates on Cellular Mechanisms
-
批准号:7086383
-
项目类别:
-
资助金额:$12.77万
-
财政年份:2000
-
负责人:William L. Dewey
-
依托单位:
EFFECTS OF OPIATES ON CELLULAR MECHANISMS
-
批准号:6523262
-
项目类别:
-
资助金额:$12.15万
-
财政年份:2000
-
负责人:William L. Dewey
-
依托单位:
Effects of Opiates on Cellular Mechanisms
-
批准号:6986267
-
项目类别:
-
资助金额:$12.77万
-
财政年份:2000
-
负责人:William L. Dewey
-
依托单位:
Effects of Opiates on Cellular Mechanisms
-
批准号:7283540
-
项目类别:
-
资助金额:$12.77万
-
财政年份:2000
-
负责人:William L. Dewey
-
依托单位:
EFFECTS OF OPIATES ON CELLULAR MECHANISMS
-
批准号:6165687
-
项目类别:
-
资助金额:$12.15万
-
财政年份:2000
-
负责人:William L. Dewey
-
依托单位:
Effects of Opiates on Cellular Mechanisms
-
批准号:7684643
-
项目类别:
-
资助金额:$12.77万
-
财政年份:2000
-
负责人:William L. Dewey
-
依托单位:
EFFECTS OF OPIATES ON CELLULAR MECHANISMS
-
批准号:6378327
-
项目类别:
-
资助金额:$12.15万
-
财政年份:2000
-
负责人:William L. Dewey
-
依托单位:
Effects of Opiates on Cellular Mechanisms
-
批准号:7490531
-
项目类别:
-
资助金额:$12.77万
-
财政年份:2000
-
负责人:William L. Dewey
-
依托单位:
SCIENTIFIC EVALUATION
-
批准号:6799047
-
项目类别:
-
资助金额:$18.5万
-
财政年份:1999
-
负责人:William L. Dewey
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: